Starter Pack Xpert® Molecular Diagnostic MRSA NxG

Features

• Control of MRSA in healthcare settings requires rapid and accurate tests to detect colonized patients Approximately 171
• 200 healthcare-associated MRSA infections are acquired annually in the European Union (EU)
• resulting in 5
• 400 attributable deaths
• more than 1 million excess days of hospitalization and € 380 million in excess in-hospital costs Between 2 and 53 million people are estimated to carry MRSA worldwide The average length of stay (LOS) for all MRSA patients in the EU is 11.5 days with an average attributable cost of € 7
• 478 per patient